Paul Wicks
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Paul Wicks is the current Vice President of Neuroscience of Sano Genetics. He previously worked at Wicks Digital Health as an Independent Co...
Investor Profile
Paul Wicks has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom.
- Strong thematic focus on Biopharma, Biotechnology, Health Care.
Stage Focus
- Series A (50%)
- Seed (50%)
Country Focus
- United Kingdom (100%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
